Catherine McCarty > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Catherine McCarty
Position
Partner
Career
Cathy McCarty is a partner in Goodwin’s Technology and Life Sciences groups, and a co-chair of Goodwin’s Intellectual Property practice group. Cathy works with clients to protect their innovations and procure intellectual property through intellectual property strategies that are integrated with each client’s business goals. She works with public and private companies of all sizes and stages of development, including venture funded start-ups, venture capital partnerships, and entities that invest in, or evaluate, pharmaceutical and life science companies and technologies.
Cathy specializes in intellectual property relating to pharmaceuticals and general chemistry matters, including small molecule drugs, salt forms, solid forms, and chemical processes. She also has worked on various litigation matters involving pharmaceutical and chemical products.
Cathy approaches each client and each matter with the drive and focus required to master the project at hand. She works to integrate the intellectual property with the practical business issues faced by the client, including scientific, financial, regulatory, and competitive issues. Her client projects are varied and include designing and managing worldwide patent estates on drug candidates, evaluating competitive landscapes to determine patentability and freedom to operate, procuring IP strategy for early stage start-up companies, performing IP due diligence for investors, and advising on license agreements, collaborations, and regulatory issues.
Education
JD, 2002, Harvard Law School / MS, Chemistry, Yale University / BS, Chemistry, Indiana University (honors)
Lawyer Rankings
United States > Intellectual property > Patents: licensing
Goodwin acts on behalf of clients in various industries, such as technology, life sciences, and financial services, in relation to developing and implementing patent procurement, management, and exploitation policies. In addition, the department also covers patent enforcement and IP litigation, and it is also active in advising on licensing and technology transactions. Catherine McCarty co-leads the team in Boston and specializes in matters concerning the pharma sector, while James Riley co-leads the department from the firm’s Silicon Valley office, representing emerging growth technology companies and venture capital firms. In Boston, Stephen Charkoudian covers technology, data and intellectual property transactions, Kingsley Taft is a key contact for clients in the biotechnology sector, and Bethany Withers chiefly advises tech companies on data, publicity rights, and intellectual property issues. Noelle Dubiansky in Washington DC frequently assists biotechnology, pharmaceutical, medical device, and various other life science enterprises with M&A transactions, strategic partnerships, and tech acquisitions.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Shareholder activism